Stock A095700 GENEXINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Genexine, Inc.

Equities

A095700

KR7095700001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
7,270 KRW +1.54% Intraday chart for Genexine, Inc. +1.39% -26.57%
2023 Genexine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Genexine, Inc. and PT Kalbe Genexine Biologics Receives the First Market Approval for Novel Long-Acting Erythropoietin, Efepoetin Alfa, from the Indonesian Food and Drug Authority CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENEXINE, INC.
Bio Therapeutic Drugs
+1.54%+1.39%-26.57%-38.70%-86.30% 223M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A095700 Stock
  4. Charts Genexine, Inc.
  5. Comparison Chart